Publique en esta revista
Información de la revista
Vol. 2. Núm. S2.
IV Simposio de Artritis Reumatoide
Páginas S38-S41 (Marzo 2006)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 2. Núm. S2.
IV Simposio de Artritis Reumatoide
Páginas S38-S41 (Marzo 2006)
Artritis reumatoide: temas de debate
Acceso a texto completo
Razones a favor del uso de antiinflamatorios no esteroideos durante la inducción de remisión de la artritis reumatoide
Visitas
...
José Javier Pérez Venegas��
Autor para correspondencia
perez.venegas@gmail.com

Correspondencia: Dr. J.J. Pérez Venegas. Sección de Reumatología. Hospital Universitario Puerta del Mar. Avda. Ana de Viya, 21. 11009 Cádiz. España.
Sección de Reumatología. Hospital Universitario Puerta del Mar. Cádiz. España
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.E. Gabriel.
The epidemiology of rheumatoid arthritis.
Rheum Dis Clin North Am, 27 (2001), pp. 269-281
[2.]
Guidelines for the Management of Rheumatoid Arthritis.
2002 Update.
Arthritis Rheum, 46 (2002), pp. 328-346
[3.]
M.H. Pillinger, S.B. Abramson.
The neutrophil in rheumatoid arthritis.
Rheum Dis Clin North Am, 21 (1995), pp. 691-714
[4.]
J.L. Masferrer, B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, et al.
Selective inhibition of inducible cycloxigenase-2 in inlammation and pain.
Proc Natl Acad Sci USA, 91 (1994), pp. 3229-3232
[5.]
G.D. Anderson, S.D. Hauser, K.L. McGarity, M.E. Bremer, P.C. Isakson, S.A. Gregory.
Selective inhibition of cyclooxigenase(COX)-2 reverse inflammation and expression of COX-2 and IL-6 in rat adjuvant arthritis.
J Clin Invest, 97 (1996), pp. 2672-2679
[6.]
I. Siegle, T. Klein, J.T. Backman.
Expression of cyclooxigenase 1 and cyclooxigenase 2 in human synovial tissue:differential elevation of cycloxigenas 2 in inflammatory joints diseases.
[7.]
J. Martel-Pelletier, J.P. Pelletier, H. Fahmi.
Cyclooxigenase–2 and prostaglandins in articular tissues.
Sem Arthritis Rheum, 33 (2003), pp. 155-167
[8.]
L. Lavagno, G. Gunella, C. Bardelli, S. Spina, L.G. Fresu, I. Viano, et al.
Antiinflammatory drugs and tumor necrosis factor alfa production from monocytes: role of transcription factor NF-kB and implication for rheumatoid arthritis therapy.
Eur J Pharmacol, 501 (2004), pp. 199-208
[9.]
A. Kajander, J. Martio.
Diclofenac Sodium and Naproxen in the treatment of rheumatoid arthritis: a comparative double blind study.
Scan J Rheumatol, 22 (1978), pp. S57-S62
[10.]
E.P. Gall, E.M. Caperton, J.E. McComb, R. Messner, C.V. Multz, M. O’Hanlan, et al.
Clinical comparison of ibuprofen, fenoprofen calcium, naproxen and tolmetin sodium in rheumatoid arthritis.
J Rheumatol, 9 (1982), pp. 402-407
[11.]
W.D. Burton, B.L. Hazleman.
Fenbufen and indomethacin: a comparative study in rheumatoid arthritis.
Clin Ther, 5 (1983), pp. 260-267
[12.]
A.L. Kolodny.
Two double blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritis.
J Rheumatol, 15 (1988), pp. 1205-1211
[13.]
T.G. Osborn, R.L. Parks, T.L. Moore.
Diflunisal vs naproxen in the management of rheumatoid arthritis.
Clin Ther, 11 (1989), pp. 737-743
[14.]
B.J. Lister, M. Poland, R.E. De Lapp.
Efficacy of nabumetone vs diclofenac,ibuprofen and piroxicam in osteoarthritis and rheumatoid arthritis.
Am J Med, 95 (2003), pp. 25-95
[15.]
S. Garner, D. Fidan, R. Frankish, M. Judd, B. Shea, T. Towheed, et al.
Celecoxib para la artritis reumatoide (revisión Cochrane traducida).
La Biblioteca Cochrane Plus, Update Sofware Ltd, (2005),
[16.]
P. Emery, H. Zeidler, T.K. Kvien, M. Guslandi, R. Naudin, H. Stead, et al.
Celecoxib vs diclofenac in long term management of rheumatoid arthritis: randomized double-blind comparison.
Lancet, 354 (1999), pp. 2106-2111
[17.]
S. Garner, D. Fidan, R. Frankish, M. Judd, T. Towheed, G. Wells, et al.
Rofecoxib para la artritis reumatoide (revisión Cochrane traducida).
La Biblioteca Cochrane Plus, Update Software Ltd, (2004),
[18.]
E. Collantes, S.P. Curtis, K. Wing Lee, N. Casas, T. McCarthy, A. Melian, et al.
A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
BMC Family Practice, 3 (2002), pp. 10
[19.]
A. Matsumoto, A. Melian, D.R. Mandel, H.H. McIlwain, D. Borenstein, P.L. Zhao, et al.
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid artritis.
J Rheumatol, 29 (2002), pp. 1623-1630
[20.]
J.E. Edwards, H.J. McQuay, R.A. Moore.
Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis:systematic review of randomized controlled trials.
[21.]
P. Gotzsche.
Non steroidal anti-inflammatory drugs.
BMJ, 320 (2000), pp. 1058-1061
[22.]
F. Wolfe, S. Zhao, N. Lane.
Preferencefor nonsteroidal antiinflammatory drug over acetaminophen by rheumatic disease patients: a survey of 1799 patients with osteoarthritis, rheumatoid arthritis and fibromyalgia.
Arthritis Rheum, 44 (2001), pp. 2451-2455
[23.]
T. Wienecke, P.C. Goetzshe.
Paracetamol vs aines para la artritis reumatoide( Revisión Cochrane traducida).
La Biblioteca Cochrane Plus, Update Software Ltd, (2005),
[24.]
E.H. Choy, D.L. Scott, G.H. Kingsley, P. Williams, J. Wojtulewski, G. Papasavvas, et al.
Treating rheumatoid artritis early with disease modifying drugs reduces joint damage: a randomized double blind trial of sulphaslazine vs diclofenac sodium.
Clin Exp Rheum, 20 (2002), pp. 351-358
[25.]
H.E. Paulus, D. Di Primeo, J.T. Sharp, H.K. Genant, B.N. Weissman, M.H. Weisman, et al.
Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3 year propective study that prohibited disease modifying antirheumatic drugs.
J Rheumatol, 31 (2004), pp. 470-481
[26.]
Scottish Intercollegiate Guidelines Network. Management of early rheumatoid arthritis. A National Clinical Guideline. December 2000.
[27.]
National Institute for Clinical Excellence. Guidance on the use of cyclooxygenase( Cox)II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. May 2004.
[28.]
Grupo GUIPCAR.
Guía de práctica clínica para el manejo de la artritis reumatoide en España.
Sociedad Española de Reumatología, (2001),
Copyright © 2006. Elsevier España S.L. Barcelona
Idiomas
Reumatología Clínica

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?